OSTX
OSTX
AMEX · Biotechnology

Os Therapies Inc

$1.65
-0.01 (-0.60%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,873.9% upside
Low Target $26.16
Average Target $32.57
High Target $50.99
Current Price $1.65
Current
$1.65
Target
$32.57
$26.16 $32.57 avg $50.99
Scenario Analysis
Bear Case
$26.16
1,485.5%
Low target
Base Case
$32.57
+1,873.9%
Avg target
Bull Case
$50.99
+2,990.3%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.25
-26.7% from high
52-Week Low
$1.15
+43.5% from low
Target vs 52W High
$32.57
+1,347.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%